Anúncio
Anúncio

TPST

TPST logo

Tempest Therapeutics, Inc. Common Stock

2.88
USD
Patrocinado
+0.09
+3.38%
08 de jan., 15:51 UTC -5
Encerrado
exchange

Pré-Mercado

2.89

+0.01
+0.49%

Relatórios de Lucros TPST

Rácio de surpresa positiva

TPST separação 21 de 37 últimas estimativas.

57%

Próximo Relatório

Data do Próximo Relatório
25 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$3.59
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
+354.43%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
-10.92%

Tempest Therapeutics, Inc. Common Stock earnings per share and revenue

On 05 de nov. de 2025, TPST reported earnings of -0.79 USD per share (EPS) for Q3 25, beating the estimate of -3.33 USD, resulting in a 76.31% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +9.10% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -3.59 USD, with revenue projected to reach -- USD, implying an aumentar of 354.43% EPS, and aumentar of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
For Q3 2025, Tempest Therapeutics, Inc. Common Stock reported EPS of -$0.79, beating estimates by 76.31%, and revenue of $0.00, 0% as expectations.
The stock price moved up 9.1%, changed from $9.12 before the earnings release to $9.95 the day after.
The next earning report is scheduled for 25 de mar. de 2026.
Based on 3 analistas, Tempest Therapeutics, Inc. Common Stock is expected to report EPS of -$3.59 and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio